Radio Taiwan International
Date: 30 July, 2020
By: John Van Trieste

Researchers at Taiwan’s National Health Research Institutes (NHRI) say that a treatment they are developing for COVID-19 is showing promise. The treatment uses monoclonal antibodies, and has shown positive results in tests on hamsters.

The director of the NHRI’s Institute of Infectious Diseases and Vaccinology, Liao Ching-len, says the antibodies target what the team calls the virus’ “Achilles heel” with extreme precision.    [FULL  STORY]